HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arden Cost-Cutting To Incur $2 Mil. Charge In Q4

This article was originally published in The Rose Sheet

Executive Summary

Elizabeth Arden's initiative to consolidate U.S. warehouse operations into one facility by March is expected to yield annualized cost savings of approximately $4 mil.-$6 mil. beginning in 2005, the fragrance marketer and distributor announced Nov. 3

You may also be interested in...



Arden “Mini” Fragrance Open Sell Initiative Aims For Maxi Mass Market Gains

Elizabeth Arden mass market revenue advanced 13% in Q2 on the strength of the firm's open sell miniature fragrance initiative in chain drug retail accounts, CEO Scott Beattie reported during a Sept. 4 earnings call

Elizabeth Arden Balances FFI's Retail Channels, Global Exposure

FFI's purchase of Elizabeth Arden from Unilever will give the fragrance distributor a more balanced brand stable across distribution channels and between domestic and overseas markets, CEO Scott Beattie said, announcing the deal Oct. 31.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011647

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel